Nephrology Journal Club

It's the #NephJC Kidney Awards 🏆 Your chance to vote for your favorite #FOAMed creators and show some love 🥰 Sign up for the newsletter to receive a ballot 🗳️ Winners to be announced at the #NephJC graduation 3/22/26 10 am EST. nephjc.com/news/nephjckid…

New in #ASNJASN: Community engagement achieved high APOL1-mediated kidney disease (AMKD) screening rates but low yield of trial-eligible participants. Read more: kidney.pub/JASN1062

We're discussing 💉REACT- renal autologous cell treatments (rilprencel) in diabetic kidney disease. Is regenerative medicine the future of nephrology❓ Come discuss 3/10/26 at 9pm on Bluesky #NephJC #NephTwitter Blog by @DrSaiVani1 and @DrAkshayaJ nephjc.com/news/rilprence…

VA in espanol para 3/10/26 discussion Gracias @dra_miliflores #NephJC #NephTwitter nephjc.com/news/2026/3/9/…

Will renal autologous cell treatments (REACT) unlock the secret to kidney regenerative medicine? #NephJC #NephTwitter Come discuss 3/10/26 at 9pm EST on Bluesky Check out the VA by @roxnonna23 nephjc.com/news/2026/3/9/…

Check out our past winners #NephTwitter #NephJC

It's the #NephJC Kidney Awards 🏆 Your chance to vote for your favorite #FOAMed creators and show some love 🥰 Sign up for the newsletter to receive a ballot 🗳️ Winners to be announced at the #NephJC graduation 3/22/26 10 am EST. nephjc.com/news/nephjckid…

World Kidney Day is coming, and we’ll celebrate the field’s momentum #NephJCshort is a reminder that some practices should stay relics. Extreme dietary restriction is archaic when modern therapies can hit same renal pathways without ritualized deprivation nephjc.com/news/2026/2/27…

#NephTwitter #MedTwitter 🩸Blood is thicker than water 🌊 Thankfully we thinned out the 2026 KDIGO Anemia Guidelines for you to peruse. Come discuss what's new. Tuesday 2/24/26 at 9pm EST on Bluesky! Summary by @meyyappannephro nephjc.com/news/kdigo-ane…

#MedTwitter #NephTwitter 🩸2026 Anemia management en espanol. Muchas gracias @dra_miliflores for the translation. nephjc.com/news/2026/2/23…

#MedTwitter #NephTwitter 🩸KDIGO has updated their anemia management guidance for the first time in a decade! Come discuss 2/24/26 at 9 pm EST on BlueSky Check out the VA by Shellie Fravel nephjc.com/news/2026/2/23…

And in honor of Bad Bunny's win at the Super Bowl 🏆, here is the INFINITI VA en Espanol #NephTwitter nephjc.com/news/2026/2/8/…

Checkout the VA for our next discussion on INFINITI, SGLT2i use in transplant patients. #NephTwitter nephjc.com/news/2026/2/8/…

Hey #NephTwitter 2/10/26 at 9 pm we'll will discuss #Flozinating into the Future & Beyond... SGLT2i in kidney transplant recipients. What's the latest evidence of risk/benefit? Do #Flozins act mechanistically the same in de-innervated kidneys? Come chat. nephjc.com/news/inifinti-…

@DGlaucomflecken must be an undercover nephrologist 1. He's not afraid of higher potassium (🎭 ICD) 2. Campaigning for K repletion at scale ✍️ #NephJC summary nephjc.com/news/potcast

To say it took a while is an understatement, because #NephJC has been around for 11 years (and still counting)... 🥁 We opened an Instagram account, so if you're around, can follow and interact 👣💞 CC: untagable @hswapnil #MedTwitter #NephTwitter

Oh, the weather outside is frightful 🥶🥶 But #NephJC is so delightful, and since you've no place to go... Come discuss POTCAST: potassium goals and cardiac arrhythmias Summary by Shellie Fravel and Clemens Weber nephjc.com/news/potcast

¿Elevar el K⁺ al rango alto-normal puede reducir las descargas del DAI y las hospitalizaciones? 🎨Resumen visual por @meyyappannephro ✍️Traducido por @dra_miliflores nephjc.com/news/2026/1/25…

🍌🥑Can pushing K⁺ to the high-normal range reduce ICD shocks and hospitalizations? 🎨 #Visualabstract by @meyyappannephro ⏰ #NephJC chat on Jan 27, 9 pm EST nephjc.com/news/2026/1/25…